#ASCO2025
LightNews LightNews
sebastianmedina.bsky.social
Excited to have shared our work at @ASCO 2025!
We developed an explainable AI pathology model to predict docetaxel benefit in high-risk localized and mHSPC. Collab w/ @eaonc @RTOGFoundation @WinshipAtEmory. #ASCO2025

ascopubs.org/doi/10.1200/...

ascopubs.org/doi/10.1200/...
ASCO Publications
ascopubs.org
June 15, 2025 at 2:47 AM
ourmbclife.bsky.social
Season 11 kicked off with a rebroadcast of updates from #ASCO2025. Dr. Ashley Schreier walks us through key research & what it could mean for people living with MBC.
🎧 Listen (all channels) or 🔗 buff.ly/b2QvK31
#OMBCL #MBC #podcast #BCSM
October 15, 2025 at 1:21 PM
ourmbclife.bsky.social
Season 11 is live!
We’re kicking things off with a rebroadcast of updates from #ASCO2025. Dr. Ashley Schreier walks us through key research & what it could mean for people living with MBC.
🎧 Listen (all channels) or 🔗 buff.ly/b2QvK31
#OMBCL #MBC #podcast #BCSM #CanSky
October 8, 2025 at 1:31 PM
ourmbclife.bsky.social
Missed our recent webinar on the report back from ASCO 2025? Watch the recording anytime to catch up on the latest #MetastaticBreastCancer research from #ASCO2025. Dr. Ashley Schreier breaks down key findings and explains their impact.
Watch here: buff.ly/Qygs1VB
#BCSMn #CanSky
August 28, 2025 at 3:17 PM
ourmbclife.bsky.social
Join us for a special #webinar on highlights from #ASCO2025 focused on #MBC. Dr. Ashley Schreier, breast oncologist at Weill Cornell Medicine, breaks down key research & what it means for those with MBC.
Register here: buff.ly/EnIRLOh
#MBCUpdates #OurMBCLife #BCSM #CanSky
July 24, 2025 at 1:29 PM
ourmbclife.bsky.social
Join us for a special #webinar on highlights from #ASCO2025 focused on #MBC. Dr. Ashley Schreier, breast oncologist at Weill Cornell Medicine, breaks down key research & what it means for those living with MBC.
Register here: buff.ly/EnIRLOh
#MBCUpdates #OurMBCLife #BCSM #CanSky
July 18, 2025 at 1:48 PM
ourmbclife.bsky.social
The OMBCL team has wrapped up another day at #ASCO2025 & was excited to learn updates to some promising studies, like the CCTG/BCTMA/Finer Trial, the Ascent-04, & Destiny Breast09 trial. Stay tuned next week for a breakdown of our takeaways from @ascocancer.bsky.social!
#mbc #BCSM #CanSky
May 31, 2025 at 9:09 PM
institutcurie.bsky.social
📣 Circulating biomarkers #ctDNA, therapeutic vaccines, new anti-tumor molecules... Institut Curie’s teams will share a lot of nice results at #ASCO25!

👉 Discover Institut Curie’s ASCO hightlights: institut-curie.org/asco2025

Looking forward to seeing you in Chicago 🤝
@ascocancer.bsky.social
May 30, 2025 at 1:03 PM
nct-heidelberg.bsky.social
Unsere Nachlese-Veranstaltung "Highlights der Jahrestagung der American Society of Clinical Oncology (ASCO)" bietet neueste Erkenntnisse aus Forschung und Praxis in kurzen, prägnanten Vorträgen.

📅 25. Juni, 16 - 19.30 Uhr, online via Zoom
💻Anmeldung bis 24. Juni 2025: indico.dkfz.de/e/ASCO2025
June 10, 2025 at 2:11 PM
nct-heidelberg.bsky.social
Das Juni-Fortbildungsprogramm:
📅4.6. 2025 // Prof. Dr. Dr. Guy Ungerechts
Zelltherapie bei soliden Tumoren

Nach der Pfingstpause findet am 25.6. die Highlights-Veranstaltung der ASCO-Jahrestagung statt. Anmeldung indico.dkfz.de/e/ASCO2025

Alle Events unter www.nct-heidelberg.de/veranstaltun...
June 3, 2025 at 4:01 PM
medthority.bsky.social
Which emerging therapies for non-muscle-invasive bladder cancer (NMIBC) could shift the treatment landscape? Catch up with key highlights from #ASCO2025 for the latest updates on the future of NMIBC care, on demand with Medthority #MedSky #ASCO #BladderCancer #OncSKy

ow.ly/Wek250WAb0s
August 5, 2025 at 3:59 PM
medthority.bsky.social
#ASCO2025 starts today! Keep an eye out for updates from the event over the next few days and make sure to visit our Oncology Hub to access congress highlights and expert reflections as soon as they're published #MedSky #MedicalEducation #Oncology

ow.ly/st2a50W1xO3
May 30, 2025 at 1:47 PM
medthority.bsky.social
As #BladderCancerAwarenessMonth draws to an end, keep an eye on our social media channels for updates on the latest in #NMIBC from #ASCO2025. Can’t attend this year’s congress? Register with Medthority today to access highlights as soon as they’re ready #MedSky #Oncology

ow.ly/seh750W0VZR
May 29, 2025 at 3:08 PM
medliveofficial.bsky.social
From May 30–June 3, the Medlive team will be in Chicago for #ASCO25! 🎉

Stop by booth 34070 to talk about how trusted, digital #HealthEducation can close clinical care gaps in #oncology.

Learn more: bit.ly/3RD319K

#MedEd #MedicalEducation #PatientEducation #ASCO #ASCO2025 @ascocancer.bsky.social
April 28, 2025 at 7:35 PM
thecancersurvivorsclub.com
New waves in kidney cancer treatment! Dr Michael Serzan shares expert insights on breakthrough therapies for early-stage kidney cancer, fresh from the 2025 ASCO Meeting. Promising days for patients. #KidneyCancer #ASCO2025 #CancerTreatment #TCSC #OncologyUpdates

www.curetoday.com/view/a-new-t...
A New Therapeutic Approach May Make Waves in Kidney Cancer Treatment
Dr. Michael Serzan provides expert takeaways on treatment updates for patients with early-stage kidney cancer following the 2025 ASCO Meeting.
www.curetoday.com
June 13, 2025 at 8:44 AM
thecancersurvivorsclub.com
An anti-inflammatory diet may help colon cancer patients live longer, new study shows. Food isn’t just fuel—it might be part of the treatment. #TCSC #ColonCancer #CancerSurvivor #AntiInflammatory #CancerDiet #ASCO2025 #Oncology #FoodAsMedicine #CancerResearch

www.nbcnews.com/health/healt...
An anti-inflammatory diet may help colon cancer patients live longer, study says
The findings suggest that food can play a major role in cancer patients' health.
www.nbcnews.com
June 4, 2025 at 7:26 AM
thecancersurvivorsclub.com
Beyond Blood Cancers: CAR T-cell therapy is expanding its reach. #Gilead & Kite are driving bold new research that could take this life-saving tech beyond leukaemia & lymphoma. #Immunotherapy #CancerResearch #TCSC #CAR_T #Oncology #Biotech #ASCO2025

www.gilead.com/stories/beyo...
Beyond Blood Cancers New Explorations in CAR T-cell Therapy
Gilead and Kite are at the forefront of the next wave of potential CAR T-cell therapy treatment options for eligible patients. Watch the video to learn more.
www.gilead.com
June 4, 2025 at 7:20 AM
thecancersurvivorsclub.com
ASCO 2025: A promising new therapy helps patients with advanced breast cancer live longer and delay chemo. Real hope for those facing aggressive disease. 💊💗 #ASCO2025 #BreastCancer #CancerTreatment #Oncology #TCSC #MedicalResearch

www.icr.ac.uk/about-us/icr...
New therapy improves breast cancer survival and delays chemotherapy
ASCO 2025: New therapy improves survival in advanced breast cancer and delays need for chemotherapy
www.icr.ac.uk
June 1, 2025 at 8:42 AM
mpnrf.bsky.social
🏆 Big moment for MPNs: PV research took the plenary stage at #ASCO2025. Dr. Andrew Kuykendall presented VERIFY trial results on rusfertide: 

✓ 62% maintained Hct <45% 
✓ Better symptom control 
✓ Fewer skin malignancies 

#MPNs #PVawareness #Rusfertide #VERIFYtrial
July 17, 2025 at 8:31 PM
iaslc.bsky.social
Join the IASLC 2025 ASCO Highlights webinar on June 27 for expert insights into the latest breakthroughs in lung cancer treatment.

👉 Register now: bit.ly/4n93NKk

#IASLC #ASCO2025 #LungCancer #Oncology #CancerResearch #ThoracicOncology #MedicalEducation @ascocancer.bsky.social
June 16, 2025 at 8:26 PM
renacerbrainmet.bsky.social
🧠 At #ASCO2025, Dr Juan Manuel Sepúlveda (Hospital 12 de Octubre & #RENACER) presented early results from the CAN-201 NDG trial testing azeliragon + standard care in glioblastoma.

📄 ascopubs.org/doi/pdf/10.1...
#NeuroOncology #ClinicalResearch #TranslationalMedicine
June 3, 2025 at 3:36 PM
cniostopcancer.bsky.social
These patients are volunteers and will not benefit from the project for their own treatments. Instead, they will contribute to generate tools and knowledge for the oncology of the future.

The team, headed by Miguel A. Quintela, already presented first results and prepare further ones for #ASCO2025.
May 26, 2025 at 12:55 PM
cniostopcancer.bsky.social
Las pacientes son voluntarias y no obtendrán un beneficio en sus tratamientos, pero contribuirán a generar herramientas y conocimiento para la oncología futuro. El equipo, coordinado por Miguel A. Quintela, ya presentó primeros resultados y prepara los siguientes para #ASCO2025.
May 26, 2025 at 12:40 PM
saiseiventures.bsky.social
The #ASCO2025 Annual Meeting is here! Sonny Dhawan, PhD, is in Chicago and excited to meet with colleagues and partners to discuss the future of #oncology.
ascocancer.bsky.social American Society of Clinical Oncology @ascocancer.bsky.social · May 30
Welcome to #ASCO25! The energy is electric as we kick off a week of scientific discovery, breakthroughs, and inspiring connections. Get ready to dive deep into oncology advancements and shape the future of cancer care.

We're thrilled you're here!
May 31, 2025 at 7:28 PM
ourbrainbankforgbm.bsky.social
At ASCO? Stop by our booth and meet Ex. Dir. Kelli Duprey and learn about our survey about GBM care disparities in the USA.
#ASCO #ASCO2025 #ASCO25 #GBM #glioblastoma #GBMDisparities #GBMRights #BTSM
June 2, 2025 at 7:55 PM